Observational studyJournal of managed care & specialty pharmacy2022

The cost impact of disease progression to metastatic castration-sensitive prostate cancer.

Quoc-Dien Trinh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.